Objective To appraise critically and to synthesize existing Maternal Kangaroo Care (MKC) intervention studies for neonatal procedural pain. Methods Four electronic databases were systematically searched and eligible studies selected by two independent reviewers. Of 93 abstracts, 12 studies met the inclusion criteria. Findings were extracted and methodology assessed based on best-synthesis methodology. Results There is evidence that MKC can significantly reduce pain from a single pain procedure in full-term infants and stable preterm infants (>26 weeks GA). All 12 MKC studies reported significant reduction in pain behavior but measures of heart rate varied. However, current approaches to data analysis cannot tell us of the magnitude of treatment effects. Conclusions Future studies need to clearly define their intervention, provide a guiding framework, explain their study methods and analyses and report effect sizes. This will help strengthen validity of the intervention and support recommendations for clinical application.
The newborn period exposes infants born ill or premature to a variety of stressors including painful procedures that may adversely affect their neurodevelopment. It is estimated that infants in intensive care undergo an average of 12 invasive procedures such as venipunctures and heel lances per day (Carbajal et al., 2008) . Immaturity, coupled with reduced abilities of these infants in regulating their autonomic, motor, and state organization heightens their vulnerability to noxious stimulation (Frank et al., 2000; Gunnar & Quevedo, 2007) . During periods of rapid brain growth, these exposures may trigger functional changes in pain systems that result in prolonged states of cutaneous hypersensitivity and hyperalgesia (Fitzgerald & Walker, 2009) .
Topical anesthetics and opioids are not used to treat procedural pain in newborns because their safety has not been established (Carbajal et al., 2005) . Maternal Kangaroo Care (MKC) is a caregiving modality that has been used to enhance the stress regulatory capacity of stable ill newborns (Vandenberg, 2007) and it is now being tested to relieve procedural pain in neonates.
MKC is defined as a naturalistic, multilevel intervention consisting of kangaroo positioning, breastfeeding, discharge and follow up (Charpak et al., 2005) . The modality originated in Columbia in 1978 when it was discovered that laying the unclothed infant vertically between the mother's breasts and under her clothing (kangaroo positioning) improved the survival of premature infants. Many benefits of MKC have been reported (Charpak et al., 2005) although mechanisms underlying the intervention remain unclear. It is thought that kangaroo positioning improves infant physiological stability, thermal regulation and state organization (DiMenna, 2006) and that being held upright exposes the infant to combinations of sensory stimulation (kinesthetic tactile auditory, olfactory, visual and vestibular) (Feldman, 2004) .
The recognized regulatory benefits of MKC have given rise to a growing number of neonatal pain MKC studies and recommendations are now being made to institute MKC as a non-pharmacological approach to treat procedural pain in premature and full-term newborns (Anand et al., 2006) ; however, these recommendations are not based on critique of the current evidence on the intervention. A systematic review on non-pharmacological neonatal pain interventions recommends MKC (Cignacco et al., 2007) , but that paper cites only one MKC study. As well, there are two Cochrane reviews on MKC (Conde-Agudelo, Diaz-Rossello, & Belizan, 2000; Moore, Anderson, & Bergman, 2007) but neither involve infant pain.
To support recommendations, this article provides a best-evidence synthesis of existing. MKC studies for neonatal pain relief. This method involves a systematic narrative review followed by a meta-analysis, if warranted (Slavin, 1995) . Our aims were fourfold: To locate existing research studies on MKC for neonatal procedural pain, to summarize characteristics and findings of the located studies, to provide a critical narrative review of the conceptual and methodological strengths and limitations of the studies using a-priori criteria, and to provide summary estimates of separate effect sizes for the difference in infant pain behavioral and physiological parameters between MKC and control conditions and an estimate of pooled effect size across studies.
Methods

Selection of Studies
We systematically searched the PUBMED, CINAHL, Web of Science and ProQuest dissertation electronic databases for published peer-reviewed papers and unpublished thesis on MKC for neonatal procedural pain from 2000 to 2009. To locate papers, the following key words and (MeSH) terms and/or their combination were used: newborn infant, infant pain, skin-to-skin-contact, kangaroo care, mother, and maternal. Also, references of eligible papers were searched.
To be included in this review, papers had to: be original studies written in the English language, have an abstract available online, be published between 2000 and 2009, involve human mothers, include premature or term born neonates (birth to 30 days of age), and involve infant procedural pain. The search yielded 93 abstracts (unpublished dissertations (n ¼ 25) and published papers (n ¼ 68) that were independently assessed by two research assistants against the above pre-specified inclusion criteria. Differences among the raters in the selection of studies were resolved by discussion and consensus was reached.
Of the 93 abstracts, the 25 abstracts of dissertations were all excluded because none pertained to infant pain. A further 55 abstracts of studies were also excluded because they were review papers (n ¼ 14), were commentaries (n ¼ 2), or they focused on unrelated topics such breastfeeding, sweet solutions, positioning, tucking, neonatal care or birth (n ¼ 39). In total, 13 papers met the inclusion criteria. Inter-rater reliability in the selection of studies was i ¼ .80.
Data Extraction and Evaluation Procedure
Data from the 13 eligible MKC studies were extracted and synthesized by the present authors who have expertise in neonatal pain and MKC. Outcomes of interest included the behavioral and physiological responses of infants to procedural pain as measured in the MKC studies. Newborns typically respond to a painful procedure by exhibiting a repertoire of distress responses (eg., crying (pitch, frequency and duration) and change in facial activity (e.g. grimacing) and body movement), and physiological stress responses [e.g. increase in heart rate (HR), respiration and blood pressure, and decrease in transcutaneous oxygen saturation (SaO 2 ) and HR variability (HRV)] (Frank, Greenberg & Stevens, 2000) . In keeping with the best-synthesis method (Slavin, 1995) , the primary author developed a-priori criteria by ensuring that they pertained to the relief of procedural pain in newborns (germaneness) and they assessed the extent to which the designs of selected MKC studies minimized internal and external validity. As per the best-synthesis by Carroll et al. (2008) , the primary author also developed the criteria to appraise the reporting of the randomized controlled interventions based on principles of the CONSORT statement (Altman et al., 2001 ). The resultant a-prior criteria are listed in Table I , panel B. Findings are then used to further screen studies for inclusion and to determine whether existing data warrant computation of effect sizes and a meta-analysis. Team members independently evaluated each of 13 studies on the presence or absence of the a-priori criteria and came to consensus on evaluation guided by substantive methodological and statistical considerations (Slavin, 1986) . Disagreements were resolved through discussion. Findings form the basis for our narrative analysis and recommendations.
Results
The 13 MKC studies were found to differ considerably in terms of their study designs, methods and methodological quality. One study that lacked a Non-MKC control group was excluded. Most of the remaining 12 studies did not report measures of variation as standard errors. These and other issues, that we discuss later, precluded a calculation of effect sizes or a meta-analysis (Slavin, 1995) . We decided against excluding any of the 12 studies with the view that the narrative critical analysis of this best-synthesis would provide an update on existing evidence and help identify areas requiring research. The major characteristics and findings of the 12 MKC studies comprising this narrative review are summarized in Table I , panel A.
Major Characteristics of the MKC Studies and Reported Findings
As Table I , panel A shows, all of the 12 MKC studies sampled clinically stable neonates with nine studies involving preterm neonates 26-36 weeks gestational age (GA), and three involving full-term neonates. MKC was evaluated before, during and after either a single routine infant heel lance in ten of the studies, or a single intra-muscular injection in the remaining two studies. In Study 1, infants received either a heel lance or a venipuncture although it was unclear how many infants received either of those two pain events or if authors controlled for known differences in infant response to those two types of pain procedures (Shah & Ohlsson, 2007) .
Six of the studies employed a crossover design where each infant was randomly assigned to two (MKC alone and regular crib care), or to four (MKC, regular crib care with and without heel lance) sets of conditions. The other six studies were parallel-group designs where infants were randomly assigned to MKC versus regular crib care, or to MKC versus 1 ml 25% glucose versus regular crib care. Sample size ranged from 10 to 74 infants in the crossover studies, and 15 to 50 infants per group in the parallel-group studies. Duration of MKC, prior to the infant pain event, averaged 25 min, but it lasted only 10 min in three studies, 3 h in another, or it was applied daily for 45 min over a 5 day period in one other study.
All 12 studies reported MKC to effectively reduce infant pain although these conclusions were based primarily on reduction in pain behavior (e.g., facial action, cry duration) and/or in SaO2. Conversely, measures of HR varied considerably. Independent of study design, HR in MKC versus control conditions was significantly higher in one study (Study 5), lower in three other studies (Studies 3, 4, 12) and not statistically significantly different in the remaining three (Studies 2, 6, 7). Notably, all of the foregoing conclusions were based on reports of statistical significance. Of the 12 studies, only Study 3 reported effect size rather than only statistical significance and it reported HRV outcomes in addition to mean HR. In that study, MKC had a moderate effect on infant HRV revealing that when infants were in MKC, they showed a more balanced and stable autonomic response to heel lance compared to incubator condition. In another study (Study 4), MKC was reported to be more effective than glucose in reducing pain behavior and resulting in less variation in HR and SaO 2 . MKC was also reported to reduce the pain response of very preterm infants (26-32 weeks GA) but the effects were reported to be less powerful and not as quick as in older preterm infants.
Critical Analysis: Strengths, Limitations and Recommendations
Methodological
As Table I , panel B shows, there is evidence of strength in study rigor amongst the 12 studies. In nine studies, the use of power analysis to calculate infant study sample size suggests that most of the evidence is based on adequately powered studies and that steps were taken to reduce Type II error. The use of the crossover design eliminates between-subject variability and helps control for prior exposure to pain which is important when studying preterm infants. Six studies reported blinding to purpose of the study and nine studies controlled for important confounders (such as infant GA and history of prior pain), either as part of the study design or analytically. In all of the parallel-group studies, subject characteristics were reported to be homogenous between infant groups. This suggests unbiased distribution of potential confounders providing further evidence of steps taken to minimize bias. As well, in nine studies, authors reported and/or explained the number of drop outs and the percentage of mothers who declined participation. These steps help to reduce selection bias.
As mentioned, there was considerable heterogeneity among studies in several key areas. Some studies made use of bias-prone data collection and measurement approaches when scoring the infant pain outcomes and some failed to report important measures. For example, in one study, rapid changes in infant pain behavior (e.g., facial action, motor activity) was scored at the bedside. No information was provided as to the training or proficiency of the staff that conducted the bedside scoring. In six other studies, scoring involved real-time coding of infant facial action from pre-recorded videotapes. Only two of those studies reported that coders were blinded to treatment group. In one study (Study 5), authors reported they placed a white sheet across the mother's chest to blind coders to treatment group. We, however, question the appropriateness of that strategy. Placing the sheet over the mother's skin, would appear to prevent the infant from making skin-to-skin contact with their mother which is the aim of the MKC treatment. In MKC, the blinding of coders is difficult to achieve because the mother's voice and her skin is often discernible to coders. However, the potential problem with studies that do not report blinding of coders is that it may be assumed Table I . that these coders may have had expectations regarding the effects of MKC versus other or no intervention and that their scorings were biased in line with these expectations. Furthermore, coder bias may be interpreted as a possible explanation for the reported discrepancy of the effects of MKC on behavioral pain measures versus HR. To promote blinding of coders, we suggest that authors of future MKC studies place a neutral skin colored bed-sheet under the head of control infants, to crop the videotaped footage so that only the face of the infant is visible and to remove sound prior to coding. A related issue was that only four studies reported inter-rater reliability between coders, making it difficult to determine the extent to which bias in measurement were addressed. This is concerning given that assessment of the efficacy of MKC relies on accuracy in the measurement of the infant pain outcomes.
In five studies, authors reported independent measures of infant pain behavior and/or physiological responses. In the remaining seven studies, authors made use of a validated composite pain scale such as the Neonatal Infant Pain Scale (NIPS) or the Premature Infant Pain Profile (PIPP). In those seven studies, measures of infant pain were reported in the form of a total pain score. While useful, the interpretation of the total pain score can, however, be misleading (Anand et al., 2006) . This is because the score may better represent data on one indicator (e.g., facial action) while obscuring data on another (e.g. HR). This issue is important because the pain response of the preterm infant is unpredictable (Fitzgerald, 1993) . Moreover, some preterm infants may be unable to exhibit a behavioral pain response (Johnston et al., 1999) or it may be difficult to detect pain related changes in HR. Hence, prudent interpretation of composite pain scores is needed. We recommend that when researchers use composite pain scales they also obtain and report separate physiological and behavioral measures of infant pain. We also recommend measures of HRV as this may provide unique information about MKC effects on cardiac autonomic modulation, especially for the preterm (Oberlander & Saul, 2002) .
The process of randomization was explained in 10 of the studies. Authors made use of computer-generated random numbers, permuted blocks, table of random numbers, and sealed envelops (some unmarked). All of these strategies help reduce selection bias and other threats to internal and external validity with the exception of sealed envelopes. A further strategy may include the use of a third party to help ensure allocation concealment. In the crossover studies, the period of washout ranged from 24 h to 14 days. These wide differences make it difficult to generalize findings or to determine if carry over effects were adequately controlled. Some of foregoing variations in study method are similar to those reported in a systematic review of MKC that did not pertain to infant pain (Conde-Agudelo et al., 2003) .
The protocol of kangaroo positioning was consistent across the 12 studies and it seems that as little as 10 min of MKC may be sufficient for analgesia. Although as noted earlier, the studies varied considerably in duration of infant exposure to MKC, in the pre-and post-assessment periods. We recommend studies to determine the optimal duration of MKC for the majority of newborns and comparative studies to examine the safety of prolonged and/or repeated infant exposure to MKC. Furthermore, we recommend that MKC be tested when provided by other family caregivers (e.g. fathers) and against or in combination with other treatments (e.g., sucrose and breastfeeding) .
Statistical
Variation in the design of the 12 studies and approaches to analysis and reporting of results prevented us from achieving our goals of conducting a meta-analysis of the 12 MKC. Data and basic descriptive measures such as means and standard deviations were available only in graphical format, requiring approximation. Moreover, raw data (e.g., mean and/or standard error of the mean) of the individual measures from study authors were not available.
Of the 12 studies, seven reported baseline measures, two partially and three did not. Five studies, based on the PIPP, did not report baseline measures of total PIPP scores. In the six parallel-group designs, the descriptive standard deviations were generally sufficient to derive appropriate confidence intervals for the mean difference, but did not generally allow for standardization for baseline differences. One study reported effect size for HRV, but the rest reported mean HR. Baseline differences were generally reported for mean HR, but the necessary standard deviations or standard errors relative to change scores (post lance -baseline) were not provided. Cross-over design studies were especially problematic. Descriptive means and standard deviations were reported, but not within-group standard deviations, though in some cases these could be inferred from inferential statistics, such as F-values. Eleven studies reported behavioral measures, four based on PIPP and three based on the NFCS. Similar issues as those confronted in HR precluded unbiased and accurate calculation of effect size and meta-analysis.
Missing data and under-reporting are serious issues that affect many clinical intervention studies. Although there are several approaches that can be used to handle missing data in a meta-analysis (Wiebe et al., 2006) , we do not believe given the large amount of missing data, high level of heterogeneity and methodological limitations, that statistical analysis would have yielded a trustworthy measure of MKC treatment effect. One of the MKC studies (Study 2) had available/usable data from which we could have calculated an effect size for infant HR, but we do not believe results of one study would be representative. We stress future studies report baseline measures of infant outcomes and measures of effect sizes.
Conceptual
None of the 12 MKC studies, except for one (Study 3), provided a guiding theoretical framework. In most cases, authors justified testing MKC on the basis of prior reports of positive MKC treatment effects. It seems that researchers were testing only the maternal-infant skin-to-skin component of the MKC modality (Charpak et al., 2005) . This may be because authors were viewing the intervention in terms of ''kangaroo'' or marsupial care (Kirsten, Bergman, & Hann, 2001 ). However, we question the conceptual adequacy of that viewpoint and whether it has limited research on the multiple dimensions of MKC and in particular on the regulatory role of the infant's mother. It is highly likely that during MKC, a mother would interact with her infant providing multiple forms of caregiving (e.g. talk, touch). Moreover, ordinary variations in maternal behavior are known to influence the expression of neural systems involved in stress reactivity in infant offspring (Hane & Fox, 2006) . Unfortunately, few MKC studies describe or control for maternal behavior. For example, in 50% of the studies mothers were instructed to not speak or touch their infants during MKC. The purpose was to keep coders blind when coding videotapes or no reason was given. As a result, it is unknown if a mother's engagement (or lack of) contributes or adversely impacts on the effectiveness of the intervention.
Specifying a guiding framework, such as Hofer's model of hidden regulators (Hofer, 1994) may help. The model postulates that various contributions of maternal caregiving function as ''hidden'' regulators that allow a mother to regulate specific and independent sources of the infant's emerging behavioral, autonomic, state, thermoregulatory emotion and stress-management systems (Feldman, Weller, Leckman, Kuint, & Eidelman, 1999) . As it pertains to MKC, these contributions can be categorized as two main components: maternal-infant skin-to skin-contact that makes available physical proximity, warmth, maternal odor and heart beat, and maternal emotional availability, soothing actions and synchrony in maternal-infant interaction. Making use of Hofer's framework may help researchers to test whether both components are needed to provide regulation or whether the first component is sufficient and whether factors known to affect maternal caregiving (eg., depression) (Reck et al., 2004 ) also affect MKC.
This review has several limitations. We did not include articles written in the non English language. Our review could be criticized because it is a narrative review and it made use of a-priori criteria rather than a quality rating scale. However, in comparing the sensitivity of Cochrane systematic reviews versus best synthesis, van der Velde et al. (2007) found that the numerical score of quality that is typically provided in a Cochrane review is too limited because it does not inform readers of important weaknesses that impact on the internal validity of studies.
Conclusion
To our knowledge, this best synthesis is the first to summarize the existing evidence of MKC studies for neonatal pain relief and to provide a critical narrative report of the methodological, statistical and conceptual strengths and limitations of this evidence. MKC is a natural intervention, without additional costs, which can easily be implemented in the neonatal unit. Based on our critical analysis, there are several conclusions that can be drawn. Current findings show that MKC significantly reduce behavioral distress from a single pain procedure compared to control conditions in full-term infants and stable preterm infants aged 26 weeks GA or older. However, the magnitude of the effects of MKC remains unclear without the reporting of separate and pooled effect sizes. Measures of effect sizes may also help clarify observed dissociation between behavioral and physiological indices of infant pain (Anand et al., 2006) . Future studies need to clearly define their intervention, provide a guiding framework, explain their study methods and analyses, and report effect sizes.
